SERA PROGNOSTICS INC. - CLASS A COMMON STOCK

Sera Prognostics Appoints Dr. Paul Kearney as Chief Data Officer

28 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Sera Prognostics to be Added to Russell 2000 Index

20 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer

15 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

Sera Prognostics Announces Publication of Health Economic Analysis Supporting PreTRM® Test-and-Treat Strategy to Improve Maternal and Infant Health

14 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit

13 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

Sera Prognostics Reports Second Quarter 2021 Financial Results

30 Aug 2021 15:05:00 By Nasdaq GlobeNewswire

Sera Prognostics’ PreTRM® Test and Treat Strategy Benefits Demonstrated by Results of Prospective, Randomized Controlled Intervention Trial Evaluating Clinical Utility

17 Aug 2021 07:00:02 By Nasdaq GlobeNewswire

Sera Prognostics Announces Pricing of Initial Public Offering

14 Jul 2021 20:03:54 By Nasdaq GlobeNewswire